Former FDA cancer chief Pazdur warns of the political 'breach' of review teams
THE SO WHAT
When a former FDA cancer chief calls out a political ‘breach’ in review teams, regulatory timelines and outcomes become less predictable inputs. Biopharma operators need to model approval as a political variable—not just a clinical one—and diversify geography and indication risk accordingly.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging Tech'If these centers aren’t thoughtfully planned and coordinated, they can place extraordinary demands on electric infrastructure, the surrounding environment and host communities': Maine becomes first US state to pass data centre construction ban
A statewide moratorium on >20 MW data centers until November 1, 2027 turns power from a procurement line item into a regulatory minefield. If your AI roadmap assumes frictionless data center expansion, you now need a state-by-state permitting and grid-risk map sitting next to your model roadmap.
Deep & Emerging TechAI Could Democratize One of Tech's Most Valuable Resources
If AI makes chip design and software–silicon co-optimization cheaper, the constraint shifts from EDA talent to access to fabs and packaging. Foundry relationships and supply-chain leverage — not just model quality — will decide who actually benefits from this ‘democratization.’
Deep & Emerging TechThe musician-turned-biotech-founder waiting to fundraise
Biotech is reminding operators that money without a commercialization and regulatory path is just expensive hope. If you’re building in regulated tech — AI in health, finance, infra — treat your go-to-market and compliance architecture as part of the science, not an afterthought to bolt on once a celebrity check clears.
The US Air Force just offered a fresh look at its new B-21 stealth bomber
A major defense program staying on schedule and budget is a reminder that when the mission is existential, governments will absorb complexity and cost to modernize. Dual-use builders should read this as a timing cue — defense is ready to operationalize advanced systems while commercial buyers are still debating pilots.